Journal
SCIENCE
Volume 323, Issue 5919, Pages 1304-1307Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1165706
Keywords
-
Categories
Funding
- Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH
- V. Miller and the Forum for Collaborative HIV Research
Ask authors/readers for more resources
Although combination therapy for HIV infection represents a triumph for modern medicine, chronic suppressive therapy is required to contain persistent infection in reservoirs such as latently infected CD4(+) lymphocytes and cells of the macrophage-monocyte lineage. Despite its success, chronic suppressive therapy is limited by its cost, the requirement of lifelong adherence, and the unknown effects of long-term treatment. This review discusses our current understanding of suppressive antiretroviral therapy, the latent viral reservoir, and the needs for and challenges of attacking this reservoir to achieve a cure.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available